BNP Paribas Financial Markets
INSY

BNP Paribas Financial Markets’s Insys Therapeutics, Inc. INSY Stock Holding History

BNP Paribas Financial Markets’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,162
Closed -$60.8K – 4621
2019
Q1 		$60.8K Buy
13,162
+6,839
+108% +$32.4K ﹤0.01% 3400
2018
Q4 		$22.1K Sell
6,323
-915
-13% -$6.36K ﹤0.01% 3076
2018
Q3 		$73K Sell
7,238
-23,867
-77% -$190K ﹤0.01% 2902
2018
Q2 		$225K Buy
31,105
+10,001
+47% +$69.7K ﹤0.01% 2387
2018
Q1 		$127K Buy
21,104
+6,271
+42% +$51.8K ﹤0.01% 3070
2017
Q4 		$143K Sell
14,833
-3,903
-21% -$25.5K ﹤0.01% 3125
2017
Q3 		$166K Buy
18,736
+5,603
+43% +$57.8K ﹤0.01% 2548
2017
Q2 		$166K Buy
13,133
+8,940
+213% +$106K ﹤0.01% 2555
2017
Q1 		$44.1K Sell
4,193
-1,173
-22% -$12.5K ﹤0.01% 2786
2016
Q4 		$49.4K Buy
5,366
+3,321
+162% +$37.5K ﹤0.01% 2844
2016
Q3 		$24.1K Buy
2,045
+1,130
+123% +$17.2K ﹤0.01% 2786
2016
Q2 		$11.8K Buy
+915
New +$13.3K ﹤0.01% 2829
2016
Q1 		– Sell
-6,610
Closed -$189K – 3328
2015
Q4 		$189K Buy
6,610
+1,747
+36% +$48.4K ﹤0.01% 1970
2015
Q3 		$138K Buy
4,863
+2,906
+148% +$107K ﹤0.01% 2188
2015
Q2 		$70.3K Buy
1,957
+1,479
+309% +$46.1K ﹤0.01% 2285
2015
Q1 		$13.9K Buy
+478
New +$12.6K ﹤0.01% 2560
2014
Q4 		– Sell
-1,158
Closed -$22.5K – 3625
2014
Q3 		$22.5K Buy
+1,158
New +$18.2K ﹤0.01% 3093

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

BNP Paribas Financial Markets's INSY Position: Q2 2019 in Review

BNP Paribas Financial Markets sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 13,162 shares — an estimated $60.8K sold.

BNP Paribas Financial Markets first reported a position in INSY in Q3 2014 and held it in 17 quarters. The position peaked at $225K in Q2 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • BNP Paribas Financial Markets reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 13,162 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $60.8K.
  • BNP Paribas Financial Markets first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 17 quarters.
  • BNP Paribas Financial Markets's Insys Therapeutics, Inc. position peaked at $225K in Q2 2018.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.